Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. - Wikidata - wikimedia - TriplyDB

Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

http://www.wikidata.org/entity/Q54146487

about

Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia Silver-coated endotracheal tubes for prevention of ventilator-associated pneumonia in critically ill patients Silver coated endotracheal tubes for prevention of ventilator-associated pneumonia in critically ill patients Antibiotics for ventilator-associated pneumonia Short course versus prolonged course antibiotic therapy for hospital-acquired pneumonia in critically ill adults Antibiotics for ventilator-associated pneumonia Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients Opinion: the clinical use of selective digestive decontamination Optimizing antibiotic therapy in the intensive care unit setting.Pro/con clinical debate: the use of a protected specimen brush in the diagnosis of ventilator associated pneumonia.Bench-to-bedside review: Therapeutic options and issues in the management of ventilator-associated bacterial pneumonia Bench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit.Gut failure in critical care: old school versus new school Inhaled Antibiotics for Gram-Negative Respiratory Infections World-wide variation in incidence of Acinetobacter associated ventilator associated pneumonia: a meta-regression Ventilator-associated pneumonia: diagnosis, treatment, and prevention Adrenergic-mediated loss of splenic marginal zone B cells contributes to infection susceptibility after stroke Optimizing pharmacodynamic target attainment using the MYSTIC antibiogram: data collected in North America in 2002.Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.A case-control study on risk factors for early-onset respiratory tract infection in patients admitted in ICU.Predictive Factors of Methicillin-Resistant Staphylococcus aureus Infection in Elderly Patients with Community-Onset Pneumonia.Impact of supra-cuff suction on ventilator-associated pneumonia prevention Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment Acute respiratory distress syndrome and nosocomial pneumonia.A week seems to be weak: tailoring duration of antibiotic treatment in Gram-negative ventilator-associated pneumonia.Comparison of the bacterial etiology of early-onset and late-onset ventilator-associated pneumonia in subjects enrolled in 2 large clinical studies.Impact of Gram stain results on initial treatment selection in patients with ventilator-associated pneumonia: a retrospective analysis of two treatment algorithms.Risk factors for infection with multidrug-resistant bacteria in non-ventilated patients with hospital-acquired pneumonia.Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis Healthcare-associated pneumonia among hospitalized patients in a Korean tertiary hospital.Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients.A novel antibiotic based long-term model of ovine smoke inhalation injury and septic shock.Staphylococcus aureus nasal colonization and subsequent infection in intensive care unit patients: does methicillin resistance matter?Pathogens in the lower respiratory tract of intensive care unit patients: impact of duration of hospital care and mechanical ventilation.Early-onset ventilator-associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment.Inadequate treatment of ventilator-associated and hospital-acquired pneumonia: risk factors and impact on outcomes Risk factors and outcomes of Stenotrophomonas maltophilia bacteraemia: a comparison with bacteraemia caused by Pseudomonas aeruginosa and Acinetobacter species.Novel toxin assays implicate Mycoplasma pneumoniae in prolonged ventilator course and hypoxemia The pulmonary physician in critical care * 4: Nosocomial pneumonia.

P2860

Q21195017-F6E17C49-88CA-49E6-B938-7399EA05DA44 Q22241905-A954BF05-865E-4280-90AD-4D3A4267BE16 Q24187916-5BB53499-ECDD-4E01-A4C8-D9CB03D5F0FF Q24235792-3C352906-97C4-45BF-8BD6-43691F0E3D08 Q24240904-69C6E64D-D977-4F27-8ED4-009FED4533DD Q24242739-D221E887-02CB-48D3-9C8C-B97A0BF7AB56 Q24248832-D768042F-14B1-49FD-815C-DA551D8A8F18 Q24651466-3FE2992A-732E-4C28-85D7-EB46BDCA7EA3 Q24795736-EBDD7344-EB78-410E-8929-70982F67B1E9 Q24796204-F7DAFBDD-20CD-4C71-A00A-E204C97F0898 Q24796504-048ECD12-21EA-48DB-BBD1-2927724ED139 Q24811492-0EE5EF78-154C-4366-BFCE-F3BE25076713 Q24813204-41144818-565B-4F35-9B54-B6067E86DA1D Q28087691-18CF5FAF-8DC1-4B40-B520-FA37BA8536FD Q28386160-01BB46C1-65CB-4DCF-AAE2-737E647D95BE Q28597168-56420B2C-B08F-419A-80CC-393D91BB0DC4 Q29012676-231EA426-3875-4758-B2EF-CC823693C687 Q30846614-F13DE456-53CB-4EAC-A0C7-C2EC0DD178BE Q30939930-0496C8E8-CFDC-4B27-A227-B64EC091088C Q31918107-CEB21B6B-CDB8-408C-9D8B-A2DC8F123036 Q33299941-8D167786-0E7D-4C0B-AC58-28D2CEEEE746 Q33567395-E2870B6B-9E91-4CC9-848F-B07A2C64E699 Q33653170-00ED1EE1-5712-4B2E-9D47-1D67E3B1AC94 Q33722082-03FA8A42-664C-40B3-A60B-A4C749B0121A Q33753655-8FD82240-BB46-4861-85B8-FCBE457F453D Q33753745-B7317296-AB90-44EF-AC28-D9E7266D3E36 Q33790696-63E51FFB-ED27-4A14-8553-A79D88074869 Q33810468-653EBA07-A046-4B2B-A64B-202CFA0FEA33 Q33824063-D4854BA0-8241-4DD5-9181-C43B79FC5437 Q33826400-A75FB342-5BD5-4929-AC70-EAD91929C82C Q33843896-8B75CFD5-70F4-4C3F-97E1-B449AD4D71DF Q34052619-59C443BA-A9C3-4979-B40C-AC06A6EA71A0 Q34103796-09A64F2A-2B7E-4E25-A7C4-A440A225861D Q34133374-D3CDF4DC-EC3C-439F-A8B4-D7EFD340B35B Q34156144-A6EE425D-54F7-4185-9869-493596244842 Q34404666-1933F9EC-50FB-4112-9C78-AF0311917576 Q34457254-16B094FB-0630-430D-A5A4-9FDF5EE9F2EE Q34466373-C391E187-9E93-4216-9530-C64B0523FDA4 Q34545624-2AEDE9CC-E0F2-4146-A847-51F450D22A24 Q34581869-5678638C-6049-4301-A926-FF7F1031978F

P2860

Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

http://www.wikidata.org/entity/Q54146487

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年学术文章

@wuu

1998年学术文章

@zh-cn

1998年学术文章

@zh-hans

1998年学术文章

@zh-my

1998年学术文章

@zh-sg

1998年學術文章

@yue

1998年學術文章

@zh

1998年學術文章

@zh-hant

name

Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

@en

Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

@nl

type

label

Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

@en

Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

@nl

prefLabel

Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

@en

Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

@nl

P1433

Q54146487-59FB6EDA-F9DD-4C17-AE0E-D8BEAB9C40CB

P1476

Q54146487-1C4F4738-0D1F-488B-913A-38BCA0DBAF2A

P2093

Q54146487-30F780E4-9D04-44F7-B874-9423FC2A484B

Q54146487-33C956B0-3648-41F7-8A42-86303B5FC460

Q54146487-7B04F377-BE12-486D-AFD4-F60F7EA0D846

Q54146487-A02F0296-62C3-4971-8F3F-ADB5D79A900C

Q54146487-D6140E1F-BF9B-4E4A-8156-3B92B9E00EF3

Q54146487-DE44E502-FB87-4ABC-B960-1961E71C4947

P2860

Q54146487-2B8D9030-07F8-4C71-A4C1-C6C437DB5CE3

Q54146487-381490C0-8C61-4295-8D21-C1B1316105A9

Q54146487-3AE899F9-0AD3-4E6A-8521-E3C6371B4FDA

Q54146487-446355CE-B0B1-4047-8B18-F9119CADF119

Q54146487-5B0F2438-D9DE-4ACB-8FBC-12082BD05477

Q54146487-6949A1FB-BD69-4C94-888F-775F2510020A

Q54146487-931E1E34-73E2-4AF4-8672-59624FB6451B

Q54146487-B0587E45-A24B-445D-AB63-C734A79D6407

Q54146487-E5E10C56-BCCB-4173-BEBA-E8E82313B2AE

Q54146487-F494AFD5-17C3-4012-94DB-F989E91967C1

P304

Q54146487-507FA7CA-E1B3-423B-8679-3A527BC12E0C

P31

Q54146487-575FAE40-1624-4601-B93A-E2784E835D30

P356

Q54146487-52E26A9B-EA26-458C-B424-15758FD0CCF5

P407

Q54146487-516A4C49-A227-4720-AF62-8B7E993F5359

P433

Q54146487-1E0E3452-E199-421B-9F9B-909FD9EFEFC8

P478

Q54146487-563181D6-63DD-40A7-84D1-CDD472ABD31B

P50

Q54146487-36FD9282-87DB-41F5-AEE1-8BF12B21C180

P577

Q54146487-E516EC30-2F82-4829-BFCA-FDCA204F55CC

P5875

Q54146487-3622FBD8-DDA8-4D11-889D-A60D992E2F6A

P698

Q54146487-C089E79A-CF03-4FC5-B07F-E1CB92DF7A3A

P921

Q54146487-7D972EDA-7547-4345-A2AE-729B73A53937

Q54146487-872EEFAB-27C0-4C33-A651-3122F608532E

P356

AJRCCM.157.2.9705064

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Ventilator-associated pneumonia caused by potentially drug-resistant bacteria

@en

P2093

Chastre J

http://www.w3.org/2001/XMLSchema#string

Combaux D

http://www.w3.org/2001/XMLSchema#string

Dombret MC

http://www.w3.org/2001/XMLSchema#string

Gibert C

http://www.w3.org/2001/XMLSchema#string

Trouillet JL

http://www.w3.org/2001/XMLSchema#string

Vuagnat A

http://www.w3.org/2001/XMLSchema#string

P2860

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

APACHE II: a severity of disease classification system

The effect of late-onset ventilator-associated pneumonia in determining patient mortality.

Incidence and risk factors of pneumonia acquired in intensive care units. Results from a multicenter prospective study on 996 patients. European Cooperative Group on Nosocomial Pneumonia.

The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamase-producing organisms.

Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay.

Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized controlled trial.

Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia.

Nosocomial pneumonia. A multivariate analysis of risk and prognosis.

Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes

P304

531-539

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/AJRCCM.157.2.9705064

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

157

http://www.w3.org/2001/XMLSchema#string

P50

M L Joly-Guillou

P577

1998-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13753833

http://www.w3.org/2001/XMLSchema#string

P698

9476869

http://www.w3.org/2001/XMLSchema#string

P921